Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (281-290 of 411) with videos related to

Pageof 42
Sort By:
International Journal of Cancer|February 20, 1995
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situD S Murphy, P McHardy, J Coutts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatinJ B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
European Journal of Gynaecological Oncology|May 23, 2012
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trialsJ Vitfell-Pedersen, T A Yap, V Moreno, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summaryS Rauz, S-Y Koay, B Foot, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full reportS Rauz, S-Y Koay, B Foot, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
Journal of Medical Virology|September 13, 2002
Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infectionC E Willoughby, K Baker, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
Pageof 42

Showing results (281-290 of 411) with videos related to

Sort By:
Pageof 42
International Journal of Cancer|February 20, 1995
Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situD S Murphy, P McHardy, J Coutts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Advanced ovarian cancer. Carboplatin versus cisplatinJ B Vermorken, W W ten Bokkel Huinink, E A Eisenhauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.
European Journal of Gynaecological Oncology|May 23, 2012
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trialsJ Vitfell-Pedersen, T A Yap, V Moreno, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summaryS Rauz, S-Y Koay, B Foot, et al.
Eye (London, England)|November 18, 2017
The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full reportS Rauz, S-Y Koay, B Foot, et al.
British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
Journal of Medical Virology|September 13, 2002
Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infectionC E Willoughby, K Baker, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
Pageof 42